In September 2019, the U.S. Food and Drug Administration (FDA) reported a discovery of N-nitrosodimethylamine (NDMA) in Zantac pills. NDMA is a known carcinogen, and has been found in other pharmaceuticals, leading to drug contamination lawsuits.
If you have taken Zantac for an extended period of time and have developed cancer, contact an experienced product liability attorney to review your case. Zantac (ranitidine) is a common heartburn medication available in prescription and over-the-counter, and may have been contaminated with the cancer-causing chemical.
In a statement, the FDA advisory stated the contamination level was between 3,000 and 26,000 times higher than what the health agency has determined to be safe.
Zantac cancer lawsuit filings will depend on when consumers ingested contaminated medications and when they were diagnosed with cancer. If you have developed stomach cancer or another cancer after regularly taking Zantac, contact The Lyon Firm for a free consultation.
Joe Lyon is a Cincinnati, Ohio Drug Injury Attorney and Product Liability Lawyer accepting plaintiffs nationwide, and will review you Zantac Cancer Lawsuit with expertise and compassion.
In April 2020, the FDA asked drug companies to recall Zantac and ranitidine products due to evidence the drugs may be contain cancer-causing contaminants.
The safety agency initially was cautious when they learned about the possibility of Zantac contamination and cancer links. But after months of warnings and many products have been pulled from the shelves at retailers and pharmacies, the FDA has initiated a Zantac Recall.
ABOUT THE LYON FIRM
Joseph Lyon has 17 years of experience representing individuals in complex litigation matters. He has represented individuals in every state against many of the largest companies in the world.
The Firm focuses on single-event civil cases and class actions involving corporate neglect & fraud, toxic exposure, product defects & recalls, medical malpractice, and invasion of privacy.
NO COST UNLESS WE WIN
The Firm offers contingency fees, advancing all costs of the litigation, and accepting the full financial risk, allowing our clients full access to the legal system while reducing the financial stress while they focus on their healthcare and financial needs.
A recent study, published in the Journal of the American Society of Nephrology (JASN), indicates that long-term use of very popular drugs used to treat heartburn, acid reflux, and ulcers may dramatically increase the patient’s risk for PPI kidney damage and kidney disease.
Doctors regularly prescribe proton pump inhibitors (PPIs) to help people who suffer from regular heartburn, ulcers, gastroesophageal reflux disease or acid reflux. The medications are especially popular because they relieve symptoms rather quickly.
However, these new findings suggest the long-term use of PPIs should be avoided because it may damage the kidneys. Studies show long-term use may not only increase the risk of developing chronic kidney disease, but may also increase the risk of its progression to total kidney failure.
In fact, patients who took PPI’s for an extended time had a 96% increased rate of total kidney failure compared to patients who took an H2 histamine receptor blocker.
If you have taken Zantac and developed cancer, please consider taking legal action, not only to receive rightful compensation, but to hold drug companies accountable for the harm they continue to cause. Only through litigation can consumer safety be ensured, as corporate entities may only see profit rather than consumer health interests.
In 2013, an estimated 15 million Americans used PPIs such as Nexium, Prilosec, Prevacid and others. This number is likely an underestimate because the medications are also available over-the-counter.
Consumers see these medications at their local drug stores and assume they are safe, however kidney specialists now say there is evidence that shows they’re not as safe as previously thought. In fact, some researcher say the odds among PPI users to develop kidney problems are almost doubled.
Those most at risk are long-term users of these particular drugs. The studies showed a graded association between duration of PPI use and risk of kidney problems, which means those who took PPIs for a longer period of time are the most likely to develop kidney issues. Patients on PPIs for one to two years had a 300 percent higher risk of kidney failure than those who used the drugs for a month or less.
Patients diagnosed with Bladder, Colorectal, Esophageal, Intestinal, Kidney, Liver, Ovarian, Pancreatic, Stomach, Testicular, or Uterine cancer after taking Zantac or ranitidine should contact The Lyon Firm.
When patients and consumers are injured by defective drugs brought to market by negligent pharmaceutical companies, those responsible may be held liable for damages. Drug companies have a lawful and ethical duty to protect American consumers.
If the drug you have been prescribed caused an injury or has been recalled, contact a healthcare professional and a defective drug lawyer to help you weigh your medical and legal options.
Following major mass tort events and high-profile lawsuits, the Institute of Medicine, National Institute of Health, and Veterans Administration proposed several new steps to balance the safety monitoring following the release of new drugs.
A few of the recommendations include funding and staffing increases, improved adverse event reporting system, and greater authority for the FDA on post-marketing safety measures.
In response to increasing public concern over a lack of post-approval authority, the Institute of Medicine, National Institute of Health, and Veterans Administration have proposed several new steps to balance the safety monitoring following the release of drug.
Currently, the FDA has little funding or ability to adequately monitor adverse events, off-label uses, compliance with post market studies. When a drug is approved, there is significant uncertainty about the long term safety. Manufacturers are only required to submit data on safety and efficacy from small controlled studies.
The pre-approval studies do not provide a clear picture on how the drug is truly interacting in the market place. A few of the recommendations include funding and staffing increases, improved adverse event reporting system, greater authority for the FDA on post-marketing safety measures.
By taking the initiative and filing a Zantac injury lawsuit, plaintiffs can receive proper compensation and hold a drug company accountable for their negligent actions. Consumer drug safety depends largely on making sure companies operate within the law and within ethical boundaries.
Contact The Lyon Firm for a free consultation if you have taken Zantac, or another heartburn medication like Prilosec, for extended periods of time (more than 3 months) and have been diagnosed with cancer at least after 3 months of taking Zantac. Joe Lyon woks with industry experts and medical teams to determine the root cause of your cancer.
Drug contamination and drug injury lawsuits can help plaintiffs recover the following damages and rightful compensation:
There are recent studies that suggest NDMA, the contaminant found in Zantac, may cause cancer and suggest exposure should be limited.
The U.S. Environmental Protection Agency (EPA) and the World Health Organization (WHO) also classify it as a carcinogen. The World Health Organization (WHO) says, “NDMA is clearly carcinogenic. There is overwhelming evidence that NDMA is mutagenic and clastogenic.”
Only recently has the U.S. Food and Drug Administration announced a Zantac cancer investigation. The FDA decision came after Zantac 150 tablets tested positive for a carcinogen. But studies decades old found an association between NDMA in Zantac and cancer. There may be evidence that allegedly indicates that Sanofi other drug companies that make Zantac (ranitidine), concealed some information.
As a result, millions of consumers may have taken heartburn medication for years without knowledge that it could have been contaminated. Zantac has been a very popular medication for those suffering from heartburn, indigestion, gastric ulcers, gastroesophageal reflux disease (GERD). However, Zantac may have caused the following cancers:
Yes. Novartis/Sandoz and Apotex have recalled Ranitidine, though a number of contaminated products may remain on store shelves or in homes.
The FDA recalled all Zantac products in April 2020, and patients should contact their doctors about alternative heartburn treatments.
Many health regulators outside the U.S. have cautioned consumers of the risks of taking Zantac. There are also numerous safer alternatives for most gastro conditions. Health Canada has asked all companies to stop distributing ranitidine drugs, noting that “current evidence suggests that NDMA may be present in ranitidine, regardless of the manufacturer.”
Walmart announced a suspension of Zantac sales, as well as other and other over-the-counter medications due to cancer concerns. CVS and Walgreens also announced they are no longer selling the medications, after the FDA said some ranitidine medications could contain low levels of toxins that could cause cancer.
Zantac, or ranitidine hydrochloride, is an antacid medication that has been around since the early 1980s. Consumers commonly use Zantac for acid reflux, heartburn, and other gastrointestinal issues.
Due to recent FDA warnings and new information released from current litigation, there is much debate about the safety of Heartburn drugs and particularly Zantac. Taking courses of any contaminated drugs can increase the risk of cancer.
While you probably will not know what drugs are and are not contaminated, it is best to be aware of the risks, and limit the use of heartburn drugs you consumer. Contact your doctor with concerns, and contact an attorney should you develop any injury related to a medication.
The FDA has established a 96 nanogram/per day limit on NDMA, and there may be more than 2,500,000 nanograms of NDMA in a single Zantac 150 mg tablet.
Plaintiffs in Zantac cancer cases claim NDMA contamination may have caused cancer, after taking regular courses of the drug for years. NDMA is known as a cancer-causing chemical and a hepatotoxin, and even short-term exposure may lead liver damage. Long-term use of contaminated drugs can increase cancer risks.
NDMA is used in industrial applications, such as aviation fuel and lubricants. NDMA may be found in food products or tobacco. There are requirements for companies who produce or use the substance in large amounts.
Joe Lyon is an experienced Cincinnati Pharmaceutical Injury Lawyer. The Lyon Firm has 17 years of experience and success representing patients and plaintiffs in all fifty states, and in a variety of complex drug injury, pharmaceutical recall and product liability matters.
Pharmaceutical lawsuits can be complex and require industry experts to determine the root cause of contamination and an illness. Mr. Lyon has worked with experts nationwide to assist individuals understand why an illness occurred and what can be done to improve their lives.
The Lyon Firm continues to aggressively, professionally, and passionately advocate for injured individuals and families against drug companies, and aims to obtain just compensation under the law.
This particular case involved claims that the blockbuster painkiller was causing heart attacks and strokes in consumers. The FDA ultimately issued a recall for the medication. Merck settled the outstanding Vioxx claims for $4.85 billion following multiple trials in both state and federal courts. Joe Lyon was co-counsel in a number of individual claims that were successfully resolved in the federal MDL. The funds received for Lyon Firm clients helped several elderly clients with additional medical and home health care.
A pharmaceutical injury case involving claims that a popular surgical medication was causing kidney failure and death. The FDA recalled the medication in question, but not before thousands of patients died due to related complications. Bayer resolved some claims for $60 Million for patients who suffered kidney failure and death as a result of using the drug Trasylol. Joseph Lyon represented a widow from Kentucky whose husband died due to kidney failure following the administration of Trasylol. The recovered funds assisted the surviving family members in resuming farming operations.